NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Monday that revenues for its fiscal second quarter increased 6 percent year over year.

For the three months ended Mar. 31, Agilent recorded $ 1.02 billion in revenues compared to $963 million in Q2 2015, and beating the average Wall Street estimate of $983.3 million. Excluding currency effects, its recently divested NMR business, and any other acquisition and divestitures, core revenue growth was 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.